Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Apple
AAPL
|
+$814M |
| 3 |
NVIDIA
NVDA
|
+$700M |
| 4 |
Broadcom
AVGO
|
+$647M |
| 5 |
Shopify
SHOP
|
+$593M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$701M |
| 2 |
Johnson & Johnson
JNJ
|
+$685M |
| 3 |
Discover Financial Services
DFS
|
+$484M |
| 4 |
Meta Platforms (Facebook)
META
|
+$407M |
| 5 |
HubSpot
HUBS
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.47% |
| 2 | Financials | 12.85% |
| 3 | Industrials | 11.86% |
| 4 | Consumer Discretionary | 10.16% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
501
Kimco Realty
KIM
$15.4B
| $271M | 0.05% |
12,894,952
-7,041,074
| -35% | -$146M |
2013 Q2
48 quarters
|
|
502
AstraZeneca
AZN
$257B
| $270M | 0.05% |
1,930,605
+26,844
| +1% | +$3.76M |
2013 Q2
48 quarters
|
|
503
Baxter International
BAX
$13.1B
| $270M | 0.05% |
8,902,918
+458,118
| +5% | +$13.9M |
2013 Q2
48 quarters
|
|
504
W.R. Berkley
WRB
$28B
| $270M | 0.05% |
3,668,436
-494,901
| -12% | -$35.5M |
2013 Q2
48 quarters
|
|
505
Camden Property Trust
CPT
$11.4B
| $268M | 0.05% |
2,375,058
+609,697
| +35% | +$70.3M |
2013 Q2
48 quarters
|
|
506
Ares Management
ARES
$25.5B
| $267M | 0.05% |
1,544,245
-812,683
| -34% | -$129M |
2018 Q4
26 quarters
|
|
507
Enphase Energy
ENPH
$4.05B
| $267M | 0.05% |
6,743,674
+1,479,153
| +28% | +$68.3M |
2018 Q1
29 quarters
|
|
508
Alexandria Real Estate Equities
ARE
$7.16B
| $267M | 0.05% |
3,676,318
+528,575
| +17% | +$39.3M |
2013 Q2
48 quarters
|
|
509
Nucor
NUE
$58.1B
| $267M | 0.05% |
2,060,114
-289,382
| -12% | -$33.8M |
2013 Q2
48 quarters
|
|
510
DELISTED
Walgreens Boots Alliance
WBA
| $266M | 0.05% |
23,141,239
-75,658
| -0.3% | -$842K |
2013 Q2
48 quarters
|
|
511
Universal Health Services
UHS
$10.9B
| $265M | 0.05% |
1,461,198
+145,730
| +11% | +$26.3M |
2013 Q2
48 quarters
|
|
512
Invesco Variable Rate Investment Grade ETF
VRIG
$1.87B
| $264M | 0.04% |
10,547,972
-1,923,765
| -15% | -$48.2M |
2016 Q4
34 quarters
|
|
513
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.93B
| $263M | 0.04% |
4,588,907
+130,557
| +3% | +$7.08M |
2013 Q2
48 quarters
|
|
514
Q2 Holdings
QTWO
$3.86B
| $262M | 0.04% |
2,803,611
+128,387
| +5% | +$10.8M |
2016 Q3
35 quarters
|
|
515
KBR
KBR
$4.59B
| $262M | 0.04% |
5,465,232
+539,565
| +11% | +$28M |
2013 Q2
48 quarters
|
|
516
Ralph Lauren
RL
$23B
| $262M | 0.04% |
955,002
-557,901
| -37% | -$138M |
2013 Q2
48 quarters
|
|
517
DELISTED
Juniper Networks
JNPR
| $262M | 0.04% |
6,556,355
+17,344
| +0.3% | +$622K |
2013 Q2
48 quarters
|
|
518
DELISTED
Interpublic Group of Companies
IPG
| $260M | 0.04% |
10,610,766
+360,987
| +4% | +$8.78M |
2013 Q2
48 quarters
|
|
519
Stride
LRN
$3.42B
| $259M | 0.04% |
1,782,020
+165,775
| +10% | +$24M |
2013 Q2
48 quarters
|
|
520
RB Global
RBA
$15.6B
| $258M | 0.04% |
2,432,811
-3,485
| -0.1% | -$357K |
2013 Q2
48 quarters
|
|
521
Federal Realty Investment Trust
FRT
$9.24B
| $258M | 0.04% |
2,712,912
+82,312
| +3% | +$7.78M |
2013 Q2
48 quarters
|
|
522
Paycom
PAYC
$11.3B
| $257M | 0.04% |
1,112,387
-120,670
| -10% | -$28.6M |
2014 Q3
43 quarters
|
|
523
Teradyne
TER
$50.8B
| $257M | 0.04% |
2,859,466
+68,568
| +2% | +$5.48M |
2013 Q2
48 quarters
|
|
524
Globant
GLOB
$1.71B
| $257M | 0.04% |
2,827,155
+1,881,940
| +199% | +$201M |
2017 Q1
33 quarters
|
|
525
Edwards Lifesciences
EW
$49.9B
| $256M | 0.04% |
3,276,041
-1,011,671
| -24% | -$75.5M |
2013 Q2
48 quarters
|
|
Similar funds
Invesco's Q2 2025 Portfolio in Review
As of Q2 2025, Invesco held 3,922 positions worth $588B, up 11% from $528B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Invesco's Q2 2025 filing shows 165 new, 1,670 increased, 1,835 reduced and 165 closed positions. Its largest new stake was QXO Inc: 27,561,664 shares worth $594M. The largest sale was UnitedHealth, an estimated $701M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q2 2025 buy was QXO Inc: 27,561,664 shares worth $594M.
- Invesco added most to Microsoft in Q2 2025, an estimated $1.45B increase.
- Invesco's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $701M.
- Invesco fully exited Discover Financial Services in Q2 2025, selling an estimated $484M.
- Invesco's ten largest holdings make up 20% of its $588B portfolio in Q2 2025.
- Invesco opened 165 new positions and closed 165 in Q2 2025.
- Invesco's portfolio value rose 11% quarter-over-quarter to $588B.
Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.